Abstracts (HTML) Autorenliste

Uerlings, R

Quantification of hepatic liver iron overload with laser ablation inductively coupled plasma mass spectrometry (LA-ICP-MS)

Uhrig, S

RSPO2 gene rearrangement – a new cancer driver in the liver

Unger, K

Platelet GPIba is a mediator and potential interventional target for NASH and subsequent liver cancer
Genetically flexible murine organoids for mechanistic and functional modeling of cholangiocarcinoma

Urban, C

Reshaping of the cellular signaling landscape under continuous stimulation of innate antiviral responses

Urban, S

Hepatitis B virus (HBV) DNA integration is not driven by viral proteins
A rapid point-of-care device for the diagnosis of Hepatitis Delta Virus infection
IFN response suppresses HDV persistence during hepatocytes proliferation in vitro
T-Cell Receptor Grafting allows Control of Hepatitis B Virus Infection
Analysis of liver biopsies reveals a strong intrahepatic reduction of HDV and inflammatory markers after treatment with Myrcludex B in combination with Tenofovir in chronic HBV/HDV infected patients
Phenotypic and functional differences of HBVcore- versus HBVpolymerase-specific CD8+ T cells in chronically HBV-infected patients with low viral load

Uschner, FE

Compartmentalization of immune response and microbial translocation in decompensated cirrhosis

Usman, Z

Absence of mutations in the HBsAg “a” determinant during REP 2139 therapy validates serum HBsAg reductions observed in the REP 102 protocol
HDVdb: Hepatitis D virus database
Mutations in hepatitis B virus surface antigen during therapy with nucleic acid polymer REP 2139-Ca have no influence on treatment outcome or its detection by diagnostic assays

Utpatel, K

MEK inhibition suppresses cholangiocarcinoma growth by restraining tumor cell proliferation and modulating tumor microenvironment